Episode 44
In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Dr. Julie Allickson, Chief Technology Officer for Mayo Clinic’s Center for Regenerative Biotherapeutics. With over 30 years pioneering regenerative medicine – from early bone marrow transplant programs to today’s cutting-edge cell and gene therapies – Julie shares her journey and insights on translating innovative therapies from discovery to clinical impact.
Together, they explore how academic medical centers are evolving to bridge the gap between research and commercialization through integrated manufacturing capabilities, multi-site clinical trials, and strategic partnerships. Julie discusses Mayo Clinic’s approach to managing 30+ clinical trials across three sites, the critical role of automation and AI in reducing costs and improving scalability, and why thinking about commercial viability early in development is essential widespread patient access.